Failure mode and effects analysis of skin electronic brachytherapy using Esteya^® unit.

ABSTRACT:

Purpose

Esteya^® (Nucletron, an Elekta company, Elekta AB, Stockholm, Sweden) is an electronic brachytherapy device used for skin cancer lesion treatment. In order to establish an adequate level of quality of treatment, a risk analysis of the Esteya treatment process has been done, following the methodology proposed by the TG-100 guidelines of the American Association of Physicists in Medicine (AAPM).

Material and methods

A multidisciplinary team familiar with the treatment process was formed. This team developed a process map (PM) outlining the stages, through which a patient passed when subjected to the Esteya treatment. They identified potential failure modes (FM) and each individual FM was assessed for the severity (S), frequency of occurrence (O), and lack of

SUBMITTER: Ibanez-Rosello B 

PROVIDER: S-EPMC5241381 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature